Sanders Morris Harris’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,720
Closed -$298K 140
2026
Q1
$298K Buy
+3,720
New +$307K 0.05% 232
2025
Q4
Sell
-4,020
Closed -$313K 123
2025
Q3
$313K Buy
+4,020
New +$314K 0.04% 227
2025
Q2
Sell
-4,020
Closed -$289K 211
2025
Q1
$289K Hold
4,020
0.04% 210
2024
Q4
$298K Hold
4,020
0.04% 221
2024
Q3
$265K Hold
4,020
0.04% 230
2024
Q2
$371K Hold
4,020
0.06% 191
2024
Q1
$384K Hold
4,020
0.07% 187
2023
Q4
$303K Hold
4,020
0.15% 144
2023
Q3
$275K Sell
4,020
-600
-13% -$48.2K 0.06% 202
2023
Q2
$424K Buy
+4,620
New +$402K 0.09% 161
2023
Q1
Sell
-4,620
Closed -$345K 183
2022
Q4
$345K Hold
4,620
0.13% 140
2022
Q3
$395K Hold
4,620
0.1% 163
2022
Q2
$449K Hold
4,620
0.1% 164
2022
Q1
$544K Hold
4,620
0.11% 152
2021
Q4
$592K Hold
4,620
0.1% 153
2021
Q3
$515K Hold
4,620
0.09% 161
2021
Q2
$490K Hold
4,620
0.1% 174
2021
Q1
$388K Hold
4,620
0.08% 193
2020
Q4
$414K Hold
4,620
0.09% 181
2020
Q3
$384K Buy
+4,620
New +$360K 0.1% 177
2020
Q2
Sell
-4,020
Closed -$216K 145
2020
Q1
$216K Hold
4,020
0.21% 103
2019
Q4
$303K Hold
4,020
0.07% 220
2019
Q3
$288K Buy
+4,020
New +$282K 0.07% 210
2016
Q4
Sell
-5,100
Closed -$205K 137
2016
Q3
$205K Buy
+5,100
New +$192K 0.06% 138

Other funds holding EW

Sanders Morris Harris's EW Position: Q2 2026 in Review

Sanders Morris Harris sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 3,720 shares — an estimated $298K sold.

Sanders Morris Harris first reported a position in EW in Q3 2016 and held it in 24 quarters. The position peaked at $592K in Q4 2021. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sanders Morris Harris reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Sanders Morris Harris sold 3,720 Edwards Lifesciences shares in Q2 2026, an estimated $298K.
  • Sanders Morris Harris first reported a position in Edwards Lifesciences in Q3 2016 and held it in 24 quarters.
  • Sanders Morris Harris's Edwards Lifesciences position peaked at $592K in Q4 2021.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.